Could a bedtime pill boost brainpower in kids with down syndrome?
NCT ID NCT05933603
First seen Apr 08, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tests a combination of two medicines (atomoxetine and oxybutynin) given at bedtime for 6 months to children with Down syndrome who have obstructive sleep apnea. The goal is to see if the treatment improves sleep breathing problems and thinking skills. The study involves 36 children aged 6 to 17 and uses sleep tests and questionnaires to measure results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Arizona
Tucson, Arizona, 86721, United States
Conditions
Explore the condition pages connected to this study.